Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DCC3076	Leo-29102	Novel Soft-Drug Inhibitor of Phosphodiesterase 4 (PDE4) for Topical Treatment of Atopic Dermatitis More description
DCC3075	Leo-134310	Novel non-steroidal glucocorticoid receptor agonist More description
DCC3074	Leniquinsin	Phosphodiesterase inhibitor, acting as a vasodilator and showing antihypertensive effects More description
DCC3073	Lenalidomide-slf	Novel Electrophilic PROTAC that degrades nuclear proteins by engaging DCAF16 More description
DCC3072	Lenaldekar	Novel inhibitor of T-cell expansion and autoimmune encephalomyelitis More description
DCC3071	Lem-06	Novel inhibitor of nuclear receptor binding SET domain 2 (NSD2), against H3K36 methylation More description
DCC3070	Lei-301	Novel potent inhibitor for the PLAAT family members, reducing the NAE levels, including anandamide, in cells overexpressing PLAAT2 or PLAAT5 More description
DCC3069	Lei-101	Novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist More description
DCC3068	Lefucoxib	Cyclooxygenase-2 (COX-2) inhibitor More description
DCC3067	Ledgf/p75-in Inhibitor-6d	Novel inhibitor of the LEDGF/p75-IN interaction, potently inhibiting both the early and late stages of HIV-1 replication More description
DCC3066	Ldt8 Dihydrochloride	Highly potent multi-target antagonists of alpha1A- and alpha1D-adrenoceptors, and 5-HT1A receptors More description
DCC3065	Ldt5 Dihydrochloride	Highly potent multi-target antagonists of both alpha1A- and alpha1D-adrenoceptors, and also of 5-HT1A receptors More description
DCC3064	Ldt409	Novel partial agonist of PPARα and PPARγ, providing distinct and favorable gene activation profiles for the treatment of diabetes and obesity More description
DCC3063	Ldt3 Dihydrochloride	Highly potent multi-target antagonists of both alpha1A- and alpha1D-adrenoceptors, and also of 5-HT1A receptors More description
DCC3062	Lds-751	Nucleic acid binding fluorescent dye More description
DCC3061	L-dopa-snme3	Precursor of 6-[18F]Fluoro-L-DOPA used for positron emission tomography (PET) scans. References: http://www.hindawi.com/journals/bmri/2014/674063/ More description
DCC3060	Ldn-73794	Competitive LRRK2 kinase inhibitor without affecting the GTPase activity More description
DCC3059	Ldn-213844	Novel ALK2 inhibitor More description
DCC3058	ldn-211898	Potent haspin kinase inhibitor More description
DCC3057	Ldn-193665	Novel potent tau kinase inhibitor, targeting CDK5/p25 and GSK3β More description
DCC3056	ldn-193594	Novel cdk5/p25 kinase inhibitor More description
DCC3055	ldn-193191	Potent and metabolically stable inhibitor of necroptosis, a regulated caspase-independent cell death pathway More description
DCC3054	Ldn-193188	Novel inhibitor of phosphatidylcholine transfer protein (PC-TP) More description
DCC3053	ldn-112006	Necroptosis inhibitor More description
DCC3052	Ldn-0130436	Novel TDP-43::GFP aggregation inhibitor More description
DCC3051	Ldn-0070977	Novel inhibitor of PERK stress-dependent eIF2α phosphorylation with no toxicity to the cells More description
DCC3050	Ldn-0044878	Novel PAK3 kinase inhibitor, inhibiting p53-inactivated cancers More description
DCC3049	Ldn-0028574	Novel Inhibitor of SIRT1; Inhibitor of the human MDM2-p53 interaction More description
DCC3048	Ldha-in-22y	Novel inhibitor of human lactate dehydrogenase A (LDHA) More description
DCC3047	Lddn-0003499	Novel Src family tyrosine kinase inhibitor with anti-inflammatory effects in response to Aß stimulation of microglia More description

Products

Customized Consultation X

Your information is safe with us. * Required Fields.